Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -345.24% is 106% below its 5-year average of -167.42%, around the middle of its 5-year range (-907.48%–70.05%).
As of the fiscal period ended Tuesday, March 31, 2026. 12.61% above its 12-month average of -395.04%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-345.24%
NET PROFIT MARGIN AVG TTM
-395.04%
NET PROFIT MARGIN AVG 3Y
-304.72%
NET PROFIT MARGIN AVG 5Y
-167.42%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+12.61%
CURRENT VS 3Y AVG
-13.30%
CURRENT VS 5Y AVG
-106.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
10.44%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-3406.94%
vs the sector median at left
Moderna, Inc.
Market Cap
$21.45B
Net Profit Margin
-345.24%
TTM Avg
-395.04%
3Y Avg
-304.72%
5Y Avg
-167.42%
Market Cap
$22.43B
Net Profit Margin
40.61%
TTM Avg
41.73%
3Y Avg
40.84%
5Y Avg
37.71%
Market Cap
$22.59B
Net Profit Margin
-44.73%
TTM Avg
-31.89%
3Y Avg
3.77%
5Y Avg
12.08%
Market Cap
$20.08B
Net Profit Margin
-2.04%
TTM Avg
-14.44%
3Y Avg
-3.94%
5Y Avg
-4.74%
Market Cap
$23.10B
Net Profit Margin
16.98%
TTM Avg
16.55%
3Y Avg
18.38%
5Y Avg
18.84%
Market Cap
$23.51B
Net Profit Margin
26.71%
TTM Avg
12.90%
3Y Avg
13.00%
5Y Avg
12.11%
Market Cap
$24.34B
Net Profit Margin
6.66%
TTM Avg
6.01%
3Y Avg
6.56%
5Y Avg
9.24%
Market Cap
$24.42B
Net Profit Margin
11.91%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $21.45B | -345.24% | -395.04% | -304.72% | -167.42% |
| STERIS plc (STE)vs › | $20.86B | 13.18% | 12.25% | 8.55% | 8.79% |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 40.61% | 41.73% | 40.84% | 37.71% |
| BioNTech SE (BNTX)vs › | $22.59B | -44.73% | -31.89% | 3.77% | 12.08% |
| Viatris Inc. (VTRS)vs › | $20.08B | -2.04% | -14.44% | -3.94% | -4.74% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 16.98% | 16.55% | 18.38% | 18.84% |
| Incyte Corporation (INCY)vs › | $23.51B | 26.71% | 12.90% | 13.00% | 12.11% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 6.66% | 6.01% | 6.56% | 9.24% |
| Waters Corporation (WAT)vs › | $24.42B | 11.91% | 20.93% | 21.85% | 22.39% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 12.02% | 8.91% | 9.15% | 11.71% |
Operating Margin
-153.3%
Net Profit Margin
-345.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -345.24% |
| 2025-12-31 | -121.83% |
| 2025-09-30 | -19.69% |
| 2025-06-30 | -580.99% |
| 2025-03-31 | -907.48% |
| 2024-12-31 | -117.15% |
| 2024-09-30 | 0.70% |
| 2024-06-30 | -578.73% |
| 2024-03-31 | -703.59% |
| 2023-12-31 | 7.71% |
| 2023-09-30 | -198.25% |
| 2023-06-30 | -401.16% |
| 2023-03-31 | 4.30% |
| 2022-12-31 | 28.45% |
| 2022-09-30 | 32.39% |
| 2022-06-30 | 48.12% |
| 2022-03-31 | 61.57% |
| 2021-12-31 | 70.05% |
| 2021-09-30 | 69.02% |
| 2021-06-30 | 65.95% |
| 2021-03-31 | 70.05% |
| 2020-12-31 | -47.74% |
| 2020-09-30 | -147.96% |
| 2020-06-30 | -175.90% |
| 2020-03-31 | -1480.87% |
| 2019-12-31 | -877.20% |
| 2019-09-30 | -722.72% |
| 2019-06-30 | -1032.29% |
| 2019-03-31 | -827.31% |
| 2018-12-31 | -399.27% |
| 2018-09-30 | -192.38% |
| 2018-06-30 | -314.03% |
| 2018-03-31 | -249.24% |
| 2017-12-31 | -41.29% |
| 2017-09-30 | -160.72% |
| 2017-06-30 | -224.15% |
| 2017-03-31 | -224.15% |
